logo
ProjectActive

BioVac - Pfizer

Sector: Raw Materials • Location: South Africa

Source: International Finance Corporation (IFC)

The project entails a financing package of $25 million to BioVac Limited (“BioVac” or the “Company”) a South African based biopharma company to support their vaccine manufacturing capabilities.  The Company is planning to expand their operations through a 2-part project the first of which involves manufacturing the Pfizer COVID-19 vaccine (fill and finish only) and IFC will finance this via a $7 m

Status
Prospective
Sector
Raw Materials, Waste Processing and Treatment, Manufacturing (Industrial), Water Supply and Storage, Government, Fertilizers, Oil and Gas, Commercial
Location
South Africa
Updated
22 Jul 2026
Source
International Finance Corporation (IFC)

ConstructChat

Ask ConstructChat about BioVac - Pfizer

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “BioVac - Pfizer” is an infrastructure initiative in the Raw Materials sector, located in South Africa. Taiyo aggregates data on it from International Finance Corporation (IFC).

Participants

Sponsoring Agency

Status

Original status

active

Taiyo status

Prospective

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

The project entails a financing package of $25 million to BioVac Limited (“BioVac” or the “Company”) a South African based biopharma company to support their vaccine manufacturing capabilities.  The Company is planning to expand their operations through a 2-part project the first of which involves manufacturing the Pfizer COVID-19 vaccine (fill and finish only) and IFC will finance this via a $7 million loan. The second component includes construction of new multi-vaccine facility.  IFC will provide $500k funding to support the bankable feasibility study for this facility (~130 million doses annually) and provide $7.5 million in equity (~12.5% stake) and a $10 million loan to support the actual development. The main facility at BioVac consists of 6 buildings spanning some 5,500 m2 in total surface area. A new building has been constructed (building E) to house the “freezer farm” as required for the storage of vaccines.  In addition, a 50-tonne capacity liquid nitrogen tank has been installed.

Original sector

other

Location

Country

South Africa

Source

Source

International Finance Corporation (IFC)

URL

More Details

Record type

Project

Sector

Raw Materials, Waste Processing and Treatment, Manufacturing (Industrial), Water Supply and Storage, Government, Fertilizers, Oil and Gas, Commercial

Article published date

2025-08-08

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project